676 related articles for article (PubMed ID: 27049263)
1. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.
Xu L; Fu Y; Li Y; Han X
Cancer Chemother Pharmacol; 2017 Aug; 80(2):235-242. PubMed ID: 28597042
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide promotes apoptosis of HepG2 cells by activating JNK signaling pathway.
Li Q; Xue AY; Li ZL; Yin Z
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3520-3526. PubMed ID: 31081108
[TBL] [Abstract][Full Text] [Related]
4. 8-Bromo-7-methoxychrysin-induced apoptosis of hepatocellular carcinoma cells involves ROS and JNK.
Yang XH; Zheng X; Cao JG; Xiang HL; Liu F; Lv Y
World J Gastroenterol; 2010 Jul; 16(27):3385-93. PubMed ID: 20632440
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
6. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
[TBL] [Abstract][Full Text] [Related]
7. [Study on the mechanism of DDP-resistance mediated by phosphate JNK in gastric cancer].
Li DW; Peng ZH; Li ZZ; Zhang YH; Zhao MZ; Wu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Mar; 11(2):159-62. PubMed ID: 18344085
[TBL] [Abstract][Full Text] [Related]
8. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
[TBL] [Abstract][Full Text] [Related]
9. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1.
Qin J; Luo M; Qian H; Chen W
Gene; 2014 Apr; 538(2):342-7. PubMed ID: 24447717
[TBL] [Abstract][Full Text] [Related]
10. Apatinib resensitizes cisplatin-resistant non-small cell lung carcinoma A549 cell through reversing multidrug resistance and suppressing ERK signaling pathway.
Liu ZL; Jin BJ; Cheng CG; Zhang FX; Wang SW; Wang Y; Wu B
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5370-5377. PubMed ID: 29243778
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1.
Ou Y; Zhai D; Wu N; Li X
Gene; 2015 Nov; 572(1):116-122. PubMed ID: 26143754
[TBL] [Abstract][Full Text] [Related]
12. VCC-1 over-expression inhibits cisplatin-induced apoptosis in HepG2 cells.
Zhou Z; Lu X; Zhu P; Zhu W; Mu X; Qu R; Li M
Biochem Biophys Res Commun; 2012 Apr; 420(2):336-42. PubMed ID: 22425983
[TBL] [Abstract][Full Text] [Related]
13. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
Lee HH; Jeong JW; Lee JH; Kim GY; Cheong J; Jeong YK; Yoo YH; Choi YH
Oncol Rep; 2013 Sep; 30(3):1257-64. PubMed ID: 23828231
[TBL] [Abstract][Full Text] [Related]
15. [Coadministration of sorafenib and cisplatin inhibits proliferation of hepatocellular carcinoma HepG2 cells in vitro].
Chen FS; Cui YZ; Luo RC; Wu J; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1684-7. PubMed ID: 18819900
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2.
Qu X; Gao H; Zhai J; Sun J; Tao L; Zhang Y; Song Y; Hu T
Eur J Pharm Sci; 2020 May; 148():105325. PubMed ID: 32259679
[TBL] [Abstract][Full Text] [Related]
17. Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.
Wu S; Zhang T; Du J
Drug Des Devel Ther; 2016; 10():3471-3481. PubMed ID: 27822011
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
[TBL] [Abstract][Full Text] [Related]
19. Liquiritin inhibits proliferation and induces apoptosis in HepG2 hepatocellular carcinoma cells via the ROS-mediated MAPK/AKT/NF-κB signaling pathway.
Wang JR; Li TZ; Wang C; Li SM; Luo YH; Piao XJ; Feng YC; Zhang Y; Xu WT; Zhang Y; Zhang T; Wang SN; Xue H; Wang HX; Cao LK; Jin CH
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1987-1999. PubMed ID: 31956937
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
Zhou Y; Ling XL
Chin J Cancer; 2010 Feb; 29(2):167-71. PubMed ID: 20109345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
